Literature DB >> 15908465

Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart.

Ravi Rajashree1, Bradford C Blunt, Polly A Hofmann.   

Abstract

Myosin light chain 2 (LC2) phosphorylation is of both physiological and pathological importance to myocardial function. The phosphatase that directly dephosphorylates LC2 is a type 1 protein phosphatase (PP1) that contains a catalytic subunit that complexes with a myosin-binding phosphatase targeting subunit (MYPT). The goal of the present study was to examine the role of MYPT in the regulation of PP1 in ventricular myocytes. In the first part of the study, regional distribution of MYPT expression and phosphorylation were determined in unstimulated hearts. The pattern of MYPT phosphorylation was inversely related to the LC2 phosphorylation spatial gradient as described by Epstein and colleagues (Davis JS, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H, and Epstein ND. Cell 107: 631-641, 2001). In the second part of the study, adult rat isolated ventricular myocytes were exposed to an alpha-adrenergic receptor agonist, and properties of MYPT, PP1, and LC2 were studied. We found MYPT associates with cardiac myofilaments, and this association increases upon alpha-adrenergic receptor stimulation. Activation of alpha-adrenergic receptors also led to a decrease in the PP1-myofilament association. Furthermore, alpha-adrenergic receptor stimulation results in phosphorylation of MYPT and LC2 and an increase in myocyte Ca(2+) sensitivity of tension that all depend on Rho kinase activation. These data support the hypothesis that alpha-adrenergic receptor activation works through Rho kinase to phosphorylate MYPT, and phosphorylated MYPT dissociates from PP1 so that PP1 is no longer physically associated with LC2. Hence, we propose a pathway for the dynamic modulation of LC2 phosphorylation through receptor-dependent phosphorylation of MYPT, and a spatial gradient of LC2 phosphorylation under basal conditions that occurs due to varied levels of phosphorylation of MYPT in ventricles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908465     DOI: 10.1152/ajpheart.00318.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

Review 1.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 2.  The significance of regulatory light chain phosphorylation in cardiac physiology.

Authors:  Sarah B Scruggs; R John Solaro
Journal:  Arch Biochem Biophys       Date:  2011-02-21       Impact factor: 4.013

Review 3.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

4.  The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling.

Authors:  Michael Grimm; Nina Mahnecke; Friederike Soja; Ali El-Armouche; Pascal Haas; Hendrik Treede; Hermann Reichenspurner; Thomas Eschenhagen
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

5.  RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.

Authors:  Jessica Lauriol; Kimberly Keith; Fabrice Jaffré; Anthony Couvillon; Abdel Saci; Sanjeewa A Goonasekera; Jason R McCarthy; Chase W Kessinger; Jianxun Wang; Qingen Ke; Peter M Kang; Jeffery D Molkentin; Christopher Carpenter; Maria I Kontaridis
Journal:  Sci Signal       Date:  2014-10-21       Impact factor: 8.192

Review 6.  Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.

Authors:  Farah Sheikh; Robert C Lyon; Ju Chen
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

7.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

Review 8.  Myofilament dysfunction in cardiac disease from mice to men.

Authors:  Nazha Hamdani; Monique de Waard; Andrew E Messer; Nicky M Boontje; Viola Kooij; Sabine van Dijk; Amanda Versteilen; Regis Lamberts; Daphne Merkus; Cris Dos Remedios; Dirk J Duncker; Attila Borbely; Zoltan Papp; Walter Paulus; Ger J M Stienen; Steven B Marston; Jolanda van der Velden
Journal:  J Muscle Res Cell Motil       Date:  2009-01-13       Impact factor: 2.698

9.  RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes.

Authors:  Mickaël Derangeon; Nicolas Bourmeyster; Isabelle Plaisance; Caroline Pinet-Charvet; Qian Chen; Fabien Duthe; Michel R Popoff; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

10.  Transmural variation in myosin heavy chain isoform expression modulates the timing of myocardial force generation in porcine left ventricle.

Authors:  Julian E Stelzer; Holly S Norman; Peter P Chen; Jitandrakumar R Patel; Richard L Moss
Journal:  J Physiol       Date:  2008-09-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.